how long have glp 1 meds been around GLP-1 Drugs and Type Diabetes: Less Insulin, Better Time in Range — What the Evidence Drugmakers are only months into

Any references to appetite signaling, energy expenditure, satiety, or food intake are limited to experimental research context only and do not imply approved human or veterinary use

Reduced body weight gain and food consumption were observed in females at the 1.0 mg/kg/day dose

In conclusion, myo-inositol and selenium supplements are promising adjuncts in thyroid care

Additional research has demonstrated the efficacy of BPC-157 in protecting against and healing gastric ulcers in animal models, highlighting its potential therapeutic applications in gastrointestinal disorders

Liu H, Huang WC, Guo N, Mao X (2020a) Application of secondary amine switchable hydrophilicity solvents for astaxanthin extraction from wet Haematococcus pluvialis

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice